Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study (Q33642314)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

blood–brain barrier

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jeffrey J. Olson

2

object named as

Jeffrey Olson

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

object named as

Jon Weingart

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Jaishri O Blakeley

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Stuart A Grossman

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xiaoying He

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jeffrey G Supko

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

New Approaches to Brain Tumor Therapy (NABTT) Consortium

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

12 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

51-58

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Molecular targeted therapies and chemotherapy in malignant gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Chemoradiotherapy in malignant glioma: standard of care and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Pharmacokinetic considerations in the treatment of CNS tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Methods to assess drug permeability across the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Diagnosis and treatment of recurrent high-grade astrocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Recent advances in the treatment of malignant astrocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Microdialysis in neurointensive care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Mechanisms of disease: the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Intracerebral microdialysis and its clinical application: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

The use of microdialysis in pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

MR contrast enhancement of intracranial lesions with Gd-DTPA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Do anticancer agents reach the tumor target in the human brain?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

28 July 2018

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9678-2

21 January 2018

Lessons learned in the development of targeted therapy for malignant gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Radionuclide imaging in drug development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Chemosensitivity of glioma cells in vitro: a meta analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Protein binding of methotrexate to human albumin and serum. A first derivative spectroscopic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029102

30 October 2018

Continuous monitoring of blood-brain barrier opening to Cr51-EDTA by microdialysis following probe injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Barriers to drug delivery in solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo protein binding of methotrexate assessed by microdialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-008-9678-2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33642314&oldid=2195604561"